首页 > 最新文献

Texas Heart Institute Journal最新文献

英文 中文
Critical Care Echocardiography-A Driven Approach to Undifferentiated Shock. 危重症超声心动图——一种治疗未分化休克的驱动方法。
IF 0.9 4区 医学 Pub Date : 2023-10-16 DOI: 10.14503/THIJ-22-8075
Pedro Salinas, Jacqueline Sohn, José L Díaz-Gómez

The clinical approach to undifferentiated shock in critically ill patients should be revised to use modern, point-of-care tools that are readily available. With the increasing availability of 2-dimensional ultrasonography and advanced Doppler capabilities, a quick, simplified, and integrated stepwise approach to shock using critical care echocardiography is proposed. Evidence supports the feasibility and usefulness of critical care echo-cardiography in enhancing diagnostic accuracy for shock, but there is a lack of systematic application of the technology in patients with undifferentiated shock. The proposed approach begins with the use of noninvasive ultrasonography with pulsed-wave Doppler capability to determine the flow state by measuring the velocity time integral of the left ventricular outflow tract. This narrative review explores the use left ventricular outflow tract velocity time integral, velocity time integral variation, limited visceral organ Doppler, and lung ultrasonography as a systematic approach for patients with undifferentiated shock.

危重患者未分化休克的临床方法应进行修订,以使用现成的现代护理点工具。随着二维超声和先进多普勒功能的日益普及,提出了一种使用重症监护超声心动图快速、简化和集成的分步治疗休克的方法。有证据支持重症监护超声心动图在提高休克诊断准确性方面的可行性和有用性,但该技术在未分化休克患者中缺乏系统应用。所提出的方法首先使用具有脉冲波多普勒能力的非侵入性超声,通过测量左心室流出道的速度-时间积分来确定血流状态。这篇叙述性综述探讨了使用左心室流出道速度-时间积分、速度-时间-积分变化、有限内脏器官多普勒和肺部超声作为治疗未分化休克患者的系统方法。
{"title":"Critical Care Echocardiography-A Driven Approach to Undifferentiated Shock.","authors":"Pedro Salinas, Jacqueline Sohn, José L Díaz-Gómez","doi":"10.14503/THIJ-22-8075","DOIUrl":"10.14503/THIJ-22-8075","url":null,"abstract":"<p><p>The clinical approach to undifferentiated shock in critically ill patients should be revised to use modern, point-of-care tools that are readily available. With the increasing availability of 2-dimensional ultrasonography and advanced Doppler capabilities, a quick, simplified, and integrated stepwise approach to shock using critical care echocardiography is proposed. Evidence supports the feasibility and usefulness of critical care echo-cardiography in enhancing diagnostic accuracy for shock, but there is a lack of systematic application of the technology in patients with undifferentiated shock. The proposed approach begins with the use of noninvasive ultrasonography with pulsed-wave Doppler capability to determine the flow state by measuring the velocity time integral of the left ventricular outflow tract. This narrative review explores the use left ventricular outflow tract velocity time integral, velocity time integral variation, limited visceral organ Doppler, and lung ultrasonography as a systematic approach for patients with undifferentiated shock.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Iliac Artery Dissection Described on Duplex Ultrasonography. 双功能超声对髂外动脉夹层的描述。
IF 0.9 4区 医学 Pub Date : 2023-10-16 DOI: 10.14503/THIJ-23-8224
Shannon M McDonnell, Pegge M Halandras, Robert S Dieter
{"title":"External Iliac Artery Dissection Described on Duplex Ultrasonography.","authors":"Shannon M McDonnell, Pegge M Halandras, Robert S Dieter","doi":"10.14503/THIJ-23-8224","DOIUrl":"10.14503/THIJ-23-8224","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyploidy in Cardiomyocytes: Machine Learning for Single Cell Analyses. 心肌细胞的多倍性:用于单细胞分析的机器学习。
IF 0.9 4区 医学 Pub Date : 2023-10-16 DOI: 10.14503/THIJ-23-8246
Jeremy Scott Mitchell, Mark Alan Sussman
powers population-based studies of polyploidy, paving the way for advanced explorations of ploidy dynamics in myocardial biology. This methodology will be used to reevaluate ploidy response to myocardial injury, repair, and regeneration.
{"title":"Polyploidy in Cardiomyocytes: Machine Learning for Single Cell Analyses.","authors":"Jeremy Scott Mitchell, Mark Alan Sussman","doi":"10.14503/THIJ-23-8246","DOIUrl":"10.14503/THIJ-23-8246","url":null,"abstract":"powers population-based studies of polyploidy, paving the way for advanced explorations of ploidy dynamics in myocardial biology. This methodology will be used to reevaluate ploidy response to myocardial injury, repair, and regeneration.","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Memoriam: Paolo Angelini (1941-2023)-A Pioneer and World-Leading Expert in Coronary Artery Anomalies. A Tribute From the International Coronary Artery Anomalies Collaborative (ICAAC). 纪念:保罗·安吉里尼(1941-2023)-冠状动脉异常的先驱和世界领先专家。来自国际冠状动脉异常协作组织(ICAAC)的致敬。
IF 0.9 4区 医学 Pub Date : 2023-10-12 DOI: 10.14503/THIJ-23-8311
Christoph Gräni, Carlos M Mery, Silvana Molossi
{"title":"In Memoriam: Paolo Angelini (1941-2023)-A Pioneer and World-Leading Expert in Coronary Artery Anomalies. A Tribute From the International Coronary Artery Anomalies Collaborative (ICAAC).","authors":"Christoph Gräni,&nbsp;Carlos M Mery,&nbsp;Silvana Molossi","doi":"10.14503/THIJ-23-8311","DOIUrl":"10.14503/THIJ-23-8311","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41216708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy. 反复静脉注射间充质基质细胞对慢性缺血性心肌病产生累积的有益作用。
IF 0.9 4区 医学 Pub Date : 2023-10-12 DOI: 10.14503/THIJ-23-8244
Xian-Liang Tang, Roberto Bolli
{"title":"Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy.","authors":"Xian-Liang Tang, Roberto Bolli","doi":"10.14503/THIJ-23-8244","DOIUrl":"10.14503/THIJ-23-8244","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Delivery of Embryonic Cells and Products. 胚胎细胞和产品的外科递送。
IF 0.9 4区 医学 Pub Date : 2023-10-10 DOI: 10.14503/THIJ-23-8263
Philippe Menasché
{"title":"Surgical Delivery of Embryonic Cells and Products.","authors":"Philippe Menasché","doi":"10.14503/THIJ-23-8263","DOIUrl":"10.14503/THIJ-23-8263","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41216709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management of Giant Unruptured Left Sinus of Valsalva Aneurysm With Severe Aortic Regurgitation. 巨大未破裂左窦主动脉瘤合并严重主动脉反流的外科治疗。
IF 0.9 4区 医学 Pub Date : 2023-10-10 DOI: 10.14503/THIJ-23-8134
Keisuke Ozawa, Kenji Kuwaki, Hidekazu Furuya, Masaomi Yamaguchi, Akiyoshi Yamamoto

Left sinus of Valsalva aneurysms are extremely rare. Concomitant aortic valve regurgitation is a comorbidity in this pathology. This case report summarizes successful surgical treatment with aortic root replacement with a modified Bentall procedure in a 49-year-old female patient who had an unruptured huge left sinus of Valsalva aneurysm with severe aortic valve regurgitation. The intraoperative assessment showed severe adhesion between the left main trunk of the coronary artery and the left sinus of Valsalva aneurysm, and meticulous adhesion detachment was required.

左侧窦性瓦尔萨尔瓦动脉瘤极为罕见。伴有主动脉瓣反流是该病的一种合并症。本病例报告总结了一名49岁女性患者的主动脉根部置换术和改良Bentall手术的成功治疗,该患者患有未破裂的巨大左窦瓦尔萨尔瓦动脉瘤,并伴有严重的主动脉瓣反流。术中评估显示,冠状动脉左主干和瓦尔萨尔瓦动脉瘤左窦之间存在严重粘连,需要细致的粘连脱离。
{"title":"Surgical Management of Giant Unruptured Left Sinus of Valsalva Aneurysm With Severe Aortic Regurgitation.","authors":"Keisuke Ozawa, Kenji Kuwaki, Hidekazu Furuya, Masaomi Yamaguchi, Akiyoshi Yamamoto","doi":"10.14503/THIJ-23-8134","DOIUrl":"10.14503/THIJ-23-8134","url":null,"abstract":"<p><p>Left sinus of Valsalva aneurysms are extremely rare. Concomitant aortic valve regurgitation is a comorbidity in this pathology. This case report summarizes successful surgical treatment with aortic root replacement with a modified Bentall procedure in a 49-year-old female patient who had an unruptured huge left sinus of Valsalva aneurysm with severe aortic valve regurgitation. The intraoperative assessment showed severe adhesion between the left main trunk of the coronary artery and the left sinus of Valsalva aneurysm, and meticulous adhesion detachment was required.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 5","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41216710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoracic Endovascular Aortic Repair With Subclavian Revascularization for Symptomatic Nonaneurysmal Aberrant Right Subclavian Artery. 胸腔内血管主动脉修补术与锁骨下血管再通术治疗症状性非动脉瘤性右侧锁骨下动脉畸形。
IF 0.9 4区 医学 Pub Date : 2022-07-01 DOI: 10.14503/THIJ-20-7489
Yuki Nakamura, Shusuke Imaoka, Takuya Yamakura, Taro Yamasumi, Haruhiko Kondoh

Aberrant right subclavian artery is a common aortic arch anomaly that can cause dysphagia as a result of compression by the aberrant artery. For patients with an aneurysm associated with an aberrant right subclavian artery, surgical or endovascular intervention is a well-described treatment. However, for patients with a nonaneurysmal aberrant right subclavian artery, treatment with thoracic endovascular aortic repair has been limited. We describe the use of thoracic endovascular aortic repair and subclavian revascularization to treat esophageal stricture in a patient with a symptomatic nonaneurysmal aberrant right subclavian artery. The patient's dysphagia was successfully relieved after the operation.

右锁骨下动脉畸变是一种常见的主动脉弓异常,可因畸变动脉的压迫而导致吞咽困难。对于右锁骨下动脉畸形伴有动脉瘤的患者,手术或血管内介入是一种成熟的治疗方法。然而,对于非动脉瘤性右侧锁骨下动脉异常的患者,胸腔内主动脉血管修补术的治疗效果有限。我们描述了使用胸腔内血管主动脉修补术和锁骨下血管再通术治疗无症状非aneurysmal 畸形右锁骨下动脉患者食管狭窄的情况。术后患者的吞咽困难得到了成功缓解。
{"title":"Thoracic Endovascular Aortic Repair With Subclavian Revascularization for Symptomatic Nonaneurysmal Aberrant Right Subclavian Artery.","authors":"Yuki Nakamura, Shusuke Imaoka, Takuya Yamakura, Taro Yamasumi, Haruhiko Kondoh","doi":"10.14503/THIJ-20-7489","DOIUrl":"10.14503/THIJ-20-7489","url":null,"abstract":"<p><p>Aberrant right subclavian artery is a common aortic arch anomaly that can cause dysphagia as a result of compression by the aberrant artery. For patients with an aneurysm associated with an aberrant right subclavian artery, surgical or endovascular intervention is a well-described treatment. However, for patients with a nonaneurysmal aberrant right subclavian artery, treatment with thoracic endovascular aortic repair has been limited. We describe the use of thoracic endovascular aortic repair and subclavian revascularization to treat esophageal stricture in a patient with a symptomatic nonaneurysmal aberrant right subclavian artery. The patient's dysphagia was successfully relieved after the operation.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"49 4","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427065/pdf/i1526-6702-49-4-e207489.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33439829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical Circulatory Support to Treat Pulmonary Embolism: Venoarterial Extracorporeal Membrane Oxygenation and Right Ventricular Assist Devices. 机械循环支持治疗肺栓塞:静脉体外膜氧合和右室辅助装置。
IF 0.9 4区 医学 Pub Date : 2020-06-01 DOI: 10.14503/THIJ-19-7025
Aneil Bhalla, Robert Attaran

Mechanical circulatory support may help patients with massive pulmonary embolism who are not candidates for systemic thrombolysis, pulmonary embolectomy, or catheter-directed therapy, or in whom these established interventions have failed. Little published literature covers this topic, which led us to compare outcomes of patients whose massive pulmonary embolism was managed with the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) or a right ventricular assist device (RVAD). We searched the medical literature from January 1990 through September 2018 for reports of adults hospitalized for massive or high-risk pulmonary embolism complicated by hemodynamic instability, and who underwent VA-ECMO therapy or RVAD placement. Primary outcomes included weaning from mechanical circulatory support and discharge from the hospital. We found 16 reports that included 181 patients (164 VA-ECMO and 17 RVAD). All RVAD recipients were successfully weaned from support, as were 122 (74%) of the VA-ECMO patients. Sixteen (94%) of the RVAD patients were discharged from the hospital, as were 120 (73%) of the VA-ECMO patients. Of note, the 8 RVAD patients who had an Impella RP System were all weaned and discharged. For patients with massive pulmonary embolism who are not candidates for conventional interventions or whose conditions are refractory, mechanical circulatory support in the form of RVAD placement or ECMO may be considered. Larger comparative studies are needed.

机械循环支持可以帮助不适合全身溶栓、肺栓塞切除术或导管引导治疗的大面积肺栓塞患者,或这些既定干预措施失败的患者。很少有已发表的文献涉及这一主题,这使我们比较了使用静脉动脉体外膜氧合(VA-ECMO)或右心室辅助装置(RVAD)治疗大面积肺栓塞患者的结果。我们检索了1990年1月至2018年9月期间的医学文献,以获取因大规模或高风险肺栓塞合并血流动力学不稳定而住院并接受VA-ECMO治疗或RVAD放置的成人的报告。主要结局包括脱离机械循环支持和出院。我们发现16份报告,包括181例患者(164例VA-ECMO和17例RVAD)。所有RVAD受者均成功脱离支持,122例(74%)VA-ECMO患者也成功脱离支持。16例(94%)RVAD患者出院,120例(73%)VA-ECMO患者出院。值得注意的是,8例使用Impella RP系统的RVAD患者均已断奶出院。对于不适合常规干预或病情难治性的大面积肺栓塞患者,可以考虑RVAD放置或ECMO形式的机械循环支持。需要更大规模的比较研究。
{"title":"Mechanical Circulatory Support to Treat Pulmonary Embolism: Venoarterial Extracorporeal Membrane Oxygenation and Right Ventricular Assist Devices.","authors":"Aneil Bhalla,&nbsp;Robert Attaran","doi":"10.14503/THIJ-19-7025","DOIUrl":"https://doi.org/10.14503/THIJ-19-7025","url":null,"abstract":"<p><p>Mechanical circulatory support may help patients with massive pulmonary embolism who are not candidates for systemic thrombolysis, pulmonary embolectomy, or catheter-directed therapy, or in whom these established interventions have failed. Little published literature covers this topic, which led us to compare outcomes of patients whose massive pulmonary embolism was managed with the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) or a right ventricular assist device (RVAD). We searched the medical literature from January 1990 through September 2018 for reports of adults hospitalized for massive or high-risk pulmonary embolism complicated by hemodynamic instability, and who underwent VA-ECMO therapy or RVAD placement. Primary outcomes included weaning from mechanical circulatory support and discharge from the hospital. We found 16 reports that included 181 patients (164 VA-ECMO and 17 RVAD). All RVAD recipients were successfully weaned from support, as were 122 (74%) of the VA-ECMO patients. Sixteen (94%) of the RVAD patients were discharged from the hospital, as were 120 (73%) of the VA-ECMO patients. Of note, the 8 RVAD patients who had an Impella RP System were all weaned and discharged. For patients with massive pulmonary embolism who are not candidates for conventional interventions or whose conditions are refractory, mechanical circulatory support in the form of RVAD placement or ECMO may be considered. Larger comparative studies are needed.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"47 3","pages":"202-206"},"PeriodicalIF":0.9,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529065/pdf/i1526-6702-47-3-202.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Surgical Endoepicardial Linear Ablation for Ventricular Tachycardia With Postinfarction Left Ventricular Aneurysm. 心外膜内线性消融术治疗室性心动过速伴梗死后左室动脉瘤。
IF 0.9 4区 医学 Pub Date : 2020-06-01 DOI: 10.14503/THIJ-18-6615
Changcheng Liu, Zhaoping Su, Liangshan Wang, Bo Li, Jin Wang, Yang Yu, Chengxiong Gu

This retrospective study evaluated the feasibility of surgical endoepicardial linear ablation for ventricular tachycardia in patients with postinfarction left ventricular aneurysm. Sixty-four patients with multivessel coronary artery disease and left ventricular aneurysm but no mural thrombosis of the aneurysm or valve disease were treated at our institution from March 2012 through July 2015. All underwent off-pump coronary artery bypass grafting and left ventricular aneurysm repair by linear plication. Twenty-three patients (35.9%) had ventricular tachycardia and underwent surgical endoepicardial linear ablation on the beating heart guided by epicardial substrate mapping with the Carto 3 system. The remaining 41 patients (64.1%) composed the no-ablation group. The effectiveness of surgical linear ablation in the ablation group was evaluated. Safety and clinical outcomes were evaluated and compared between the groups. The ventricular tachycardia recurrence rate in the ablation group was 17.4% in the immediate postoperative period and 23.8% at last follow-up (39 ± 21 mo). Early (<30-d) mortality rates were 8.7% in the ablation group and 4.9% in the no-ablation group (P=0.41); the respective late mortality rates were 19.1% and 18% (P=0.70). Multivariate Cox regression analysis indicated that preoperatively poor left ventricular function was an independent risk factor for early and late death in both groups. The groups were similar in terms of the need for postoperative mechanical circulatory support, intensive care unit stay, and cumulative survival rate. We conclude that, for carefully selected candidates, surgical endoepicardial linear ablation combined with off-pump coronary artery bypass grafting and left ventricular aneurysm linear plication is a feasible treatment for ventricular tachycardia with postinfarction left ventricular aneurysm.

本回顾性研究评估了手术心外膜内线性消融治疗梗死后左心室动脉瘤患者室性心动过速的可行性。2012年3月至2015年7月在我院治疗了64例多支冠状动脉疾病和左心室动脉瘤患者,但没有动脉瘤壁血栓形成或瓣膜疾病。所有患者均行非体外循环冠状动脉搭桥术和左室动脉瘤线性应用修复术。23例(35.9%)患者室性心动过速,在Carto - 3系统的心外膜基底标测引导下对跳动的心脏行心外膜内线性消融手术。其余41例(64.1%)为不消融组。对消融组行线性消融的疗效进行评价。评估和比较两组之间的安全性和临床结果。消融组室性心动过速术后复发率为17.4%,末次随访(39±21个月)复发率为23.8%。早期(
{"title":"Surgical Endoepicardial Linear Ablation for Ventricular Tachycardia With Postinfarction Left Ventricular Aneurysm.","authors":"Changcheng Liu,&nbsp;Zhaoping Su,&nbsp;Liangshan Wang,&nbsp;Bo Li,&nbsp;Jin Wang,&nbsp;Yang Yu,&nbsp;Chengxiong Gu","doi":"10.14503/THIJ-18-6615","DOIUrl":"https://doi.org/10.14503/THIJ-18-6615","url":null,"abstract":"<p><p>This retrospective study evaluated the feasibility of surgical endoepicardial linear ablation for ventricular tachycardia in patients with postinfarction left ventricular aneurysm. Sixty-four patients with multivessel coronary artery disease and left ventricular aneurysm but no mural thrombosis of the aneurysm or valve disease were treated at our institution from March 2012 through July 2015. All underwent off-pump coronary artery bypass grafting and left ventricular aneurysm repair by linear plication. Twenty-three patients (35.9%) had ventricular tachycardia and underwent surgical endoepicardial linear ablation on the beating heart guided by epicardial substrate mapping with the Carto 3 system. The remaining 41 patients (64.1%) composed the no-ablation group. The effectiveness of surgical linear ablation in the ablation group was evaluated. Safety and clinical outcomes were evaluated and compared between the groups. The ventricular tachycardia recurrence rate in the ablation group was 17.4% in the immediate postoperative period and 23.8% at last follow-up (39 ± 21 mo). Early (<30-d) mortality rates were 8.7% in the ablation group and 4.9% in the no-ablation group (P=0.41); the respective late mortality rates were 19.1% and 18% (P=0.70). Multivariate Cox regression analysis indicated that preoperatively poor left ventricular function was an independent risk factor for early and late death in both groups. The groups were similar in terms of the need for postoperative mechanical circulatory support, intensive care unit stay, and cumulative survival rate. We conclude that, for carefully selected candidates, surgical endoepicardial linear ablation combined with off-pump coronary artery bypass grafting and left ventricular aneurysm linear plication is a feasible treatment for ventricular tachycardia with postinfarction left ventricular aneurysm.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"47 3","pages":"194-201"},"PeriodicalIF":0.9,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529068/pdf/i1526-6702-47-3-194.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38534953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Texas Heart Institute Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1